Tick-borne encephalitis vaccine, TicoVac, receives FDA approval

By NewsDesk @infectiousdiseasenews In a follow-up report from February, the U.S. Food and Drug Administration (FDA) has approved TICOVACTM (tick-borne encephalitis (TBE) vaccine) for active immunization to prevent TBE in individuals 1 year of age and older, according to an announcement earlier this month. TICOVACTM is the only FDA-approved vaccine to help protect U.S. adults and [...]

The post Tick-borne encephalitis vaccine, TicoVac, receives FDA approval appeared first on Outbreak News Today.